Login to Your Account

Financings Roundup

Proximagen Defies Gloomy UK Financing Trends, Raises £50M

By Jennifer Boggs

Monday, June 8, 2009
Proximagen Neuroscience plc is aiming to raise £50 million (US$80 million) through the placement of 35.7 million shares, in what the firm said is one of the largest UK biotech financings in the past decade. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription